May 21, 2022
Category: Uncategorized
Natural Immunity 97 Percent Effective Against Severe COVID-19 After 14 Months: Study
July 9, 2022 By Zachary Stieber
The protection against severe illness from so-called natural immunity remains superior to the protection bestowed by COVID-19 vaccines, according to a new study.
People who survived COVID-19 infection and were not vaccinated had sky-high protection against severe or fatal COVID-19, researchers in Qatar found.
“Effectiveness of primary infection against severe, critical, or fatal COVID-19 reinfection was 97.3 percent … irrespective of the variant of primary infection or reinfection, and with no evidence for waning. Similar results were found in sub-group analyses for those ≥50 years of age,” Dr. Laith Abu-Raddad, with Weill Cornell Medicine-Qatar, and colleagues said after studying long-term natural immunity in unvaccinated people.
That percentage is higher than the protection from COVID-19 vaccines, according to other studies and real-world data.
Swedish researchers, for instance, found in May that two doses of a vaccine were just 54 percent effective against the Omicron variant of the CCP (Chinese Communist Party) virus, which causes COVID-19.
South African scientists, meanwhile, found the effectiveness of the AstraZeneca and Pfizer vaccines peaked at 88 percent, and quickly dropped to 70 percent or lower.
The Qatar group found natural immunity for over 14 months after a person’s first infection “remains very strong, with no evidence for waning, irrespective of variant.”
The study was published ahead of peer review on the website medRxiv.
Few researchers have studied natural immunity long-term among unvaccinated persons, in part because many of the people have eventually received a COVID-19 vaccine.
The vaccines, meanwhile, have waned against both infection and severe illness over time, triggering recommendations for booster doses, with some Americans even getting five doses within 10 months.
The vaccines were once said to provide close to 100 percent protection against symptomatic infection. They now provide under 50 percent protection against infection after a short period of time, even after booster doses, following the emergence of Omicron.
That strain and its subvariants are dominant in countries around the world, including the United States and Qatar.
Natural immunity was thought to provide strong protection against reinfection. But the Qatari researchers found it also provides poor protection against reinfection from Omicron.
Pre-Omicron infection against pre-Omicron reinfection was as high as 90.5 percent, and remained around 70 percent by the 16th month, according to the study. But pre-Omicron infection against Omicron reinfection was just 38 percent effective, although it was higher among people infected with the original Wuhan strain or with the Delta variant, and lower among those who got sick from the Alpha or Beta strains.
Modeling signaled a drop to zero percent protection by 18 months, but the shielding still appears to last longer than that of vaccines, researchers said.
“Vaccine immunity against Omicron subvariants lasts for <6 months but pre-Omicron natural immunity, assuming Gompertz decay, may last for just over a year,” they wrote.
Limitations of the study included differences in testing frequency among the cohorts studied, and depletion of groups who had a COVID-19 infection due to deaths.
UK Parliament vaccine debate
Nov 10, 2022
Dr. John Campbell
“MYSTERIOUS” CLOTTING PHENOMENON
Nov 2, 2022
Cases of fibrous clots have mysteriously been popping up in the fully vaccinated and recently deceased. UK based John O’Looney joins me to discuss the most contentious subject on social media.
A Tale of Two Tennis Players
Oct 22, 2022
On March 13, 2021, the European Medicines Agency issued an announcement. Based on two large “French and Nordic” studies, the EMA’s safety committee (PRAC) reviewed the risk of myocarditis and pericarditis after receiving COVID-19 vaccines produced by Pfizer and Moderna, and reached the following conclusion:
Overall, the outcome of the review confirms the risk of myocarditis and pericarditis, which is already reflected in the product information for these two vaccines, and provides further details on these two conditions.
An Update on College Mandates ⋆ Brownstone Institute
Sept 20, 2022
When evaluating whether the ACHA’s [American College Health Association] recommendations are unbiased and ethically sound, we should seriously consider the funding the ACHA receives from Pfizer and the $2 million grant it received from the CDC to “promote COVID-19 vaccine confidence.”
https://brownstone.org/articles/an-update-on-college-mandates/
Peer-Reviewed Proof: COVID Vaccines Causing More Harm Than Good
Oct 4, 2022
A peer-reviewed scientific review in the Journal of Insulin Resistance, written by cardiologist Dr. Aseem Malhotra, calls for the immediate suspension of all COVID-19 shots as real-world data show they cause more harm than good.
Dr. Ryan Cole on the Increase in Cancers, Clotting, and Deaths Since 2021
May 13, 2022Â Interview by Chris Wark ( from chrisbeatcancer.com )
Ryan Cole, MD is a board-certified Anatomy and Clinical Pathologist, with Fellowships in Surgical Pathology and Dermatopathology. He did Ph.D. research in Immunology with subsequent training at the Mayo Clinic. Dr. Cole has seen over 500,000 patients in his 26-year career and runs the largest independent medical lab in the State of Idaho and one of the largest in the Pacific Northwest.
There are many drugs on the market known to increase the risk of cancer and Dr. Ryan Cole was one of the first to sound the alarm about the increase in cancers coming through his lab after the rollout of certain experimental emergency-use injectable drugs in 2021. You know the ones.
And for speaking out against these dangerous new drugs that were rushed to market with no long-term safety testing (and no testing for carcinogenicity), he has been attacked, slandered, lost significant income, and has mounting legal bills.
Dr. Ryan Cole is a brilliant and courageous physician who is committed to telling the truth about what’s happening. He has risked his reputation and career to do this. He has nothing to gain and everything to lose.
Dr. Cole would have more money today and a “good reputation” if he had kept quiet about his findings. It was an honor to share the stage and to spend time with him behind the scenes.
My interview with Dr. Cole was censored by YouTube immediately after we uploaded it for “violating community guidelines” before anyone even saw it. And my YouTube account is currently locked for 7 days, during which time I can’t post any new videos.
YouTube also banned my interview with Dr. Stephanie Seneff last year.
Remember, at no time in history have the people censoring information been the good guys.
This interview is a must-watch.
Please note: My microphone setup failed on the road (argh) and I had to use the built-in iPhone mic, which picked up a lot of wind noise. We were able to reduce the wind noise in editing, but we sound like we are in a tin can. Ladies and gentlemen, I am a professional. Enjoy!
Despite Incomplete Safety Trials, the Food and Drug Administration (FDA) Grants Full Approval to Pfizer-BioNTech’s COMIRNATY® for Adolescents 12-15 Years of Age
Sept 4, 2022 by Chris Flowers, M.D. based on findings by Team 1 physician and investigator, C.T.
Without a completed safety study or expert committee review, the FDA issued a supplemental Biologics License Application (“sBLA”) approval letter granting full FDA approval to Pfizer-BioNTech’s COMIRNATY® COVID-19 mRNA vaccine for use in children ages 12-15. This was done even though safety study completion, on which approval should be based, will not be completed until May 31, 2023. [https://www.fda.gov/media/159727/download and https://www.pfizer.com/news/announcements/pfizer-and-biontech-announce-us-fda-approval-their-covid-19-vaccine-comirnatyr] Additionally, the approval was issued even though COMIRNATY is still not available in the United States. [DeMasi, Maryanne. “Is Pfizer’s FDA-approved COMIRNATY Vaccine Available in the US?” Brownstone Institute, May 22, 2022. https://brownstone.org/articles/is-pfizers-fda-approved-comirnaty-vaccine-available-in-the-us/] Thus, the FDA has approved a commercial drug for children without appropriate evidence of safety.